IGF-1 LR3 1mg is a synthetic peptide analog of insulin-like growth factor-1 (IGF-1), designed for enhanced stability and extended activity in research environments. It is widely studied in biochemical and cellular biology research due to its powerful role in growth signaling, cell differentiation, and metabolic regulation pathways.
Unlike native IGF-1, this modified version—known as IGF-1 LR3—has been structurally altered to increase its half-life and reduce binding affinity to IGF-binding proteins. This modification allows it to remain active in research models for longer periods, making it especially valuable for experimental studies involving cellular growth and metabolic response analysis.
IGF-1 LR3 1mg is typically supplied as a lyophilized (freeze-dried) peptide powder. This form is commonly used in research peptides because it preserves molecular stability and ensures long-term storage viability when kept under appropriate conditions.
The 1mg dosage refers to the total amount of peptide contained in each vial, allowing researchers to accurately measure and prepare solutions based on experimental requirements. Before use in laboratory settings, IGF-1 LR3 is generally reconstituted using sterile solutions according to established scientific protocols.
This compound is strictly intended for research purposes only and is not approved for human consumption or therapeutic use in many jurisdictions.
IGF-1 LR3 is a modified form of the naturally occurring insulin-like growth factor-1. The “LR3” modification involves a substitution in the amino acid sequence that significantly increases its biological stability and reduces its interaction with IGF-binding proteins (IGFBPs). These binding proteins normally regulate and limit the activity of IGF-1 in the body.
By reducing this binding effect, IGF-1 LR3 remains in a more active and unbound state for a longer duration in experimental systems. This extended activity is one of the key reasons it is widely used in research settings focused on growth signaling and metabolic pathways.
The structural modification also enhances its suitability for studying prolonged receptor activation and downstream signaling effects.
In scientific research, IGF-1 LR3 is known to interact with the IGF-1 receptor (IGF1R), a receptor tyrosine kinase involved in regulating cellular growth, survival, and differentiation. When IGF-1 LR3 binds to this receptor, it activates intracellular signaling cascades that influence protein synthesis, glucose metabolism, and cell proliferation.
One of the most studied pathways activated by IGF-1 LR3 is the PI3K/Akt/mTOR signaling pathway, which plays a central role in cellular growth and anabolic processes. Another important pathway includes MAPK/ERK signaling, which is associated with cell division and gene expression regulation.
Because of its enhanced stability, IGF-1 LR3 allows researchers to observe prolonged receptor activation effects compared to native IGF-1, making it a valuable tool in controlled experimental studies.
IGF-1 LR3 1mg is used in a variety of laboratory and scientific research contexts, including:
These applications help researchers better understand how growth factors influence biological systems at the molecular and cellular levels.
IGF-1 LR3 is especially useful in studies where extended receptor activation is required to observe long-term biological responses.
Proper storage is essential to maintain the integrity of IGF-1 LR3 1mg. In its freeze-dried form, the peptide should be stored in a cool, dry environment, away from direct sunlight and moisture exposure. This helps preserve its structural stability over time.
After reconstitution, IGF-1 LR3 is typically stored under refrigeration and handled using sterile laboratory techniques. Researchers avoid repeated freeze-thaw cycles, as these can degrade peptide structure and reduce experimental reliability.
Following correct storage procedures is critical for maintaining consistent and reproducible research outcomes.
IGF-1 LR3 has become an important tool in modern biochemical and physiological research because it provides a more stable and longer-acting version of IGF-1. This allows scientists to study growth factor signaling with greater clarity and over extended time periods.
One of its key scientific advantages is its reduced interaction with IGF-binding proteins, which normally regulate the availability of IGF-1 in biological systems. By minimizing this interaction, IGF-1 LR3 provides a clearer picture of receptor-level activity and downstream signaling effects.
Researchers also value IGF-1 LR3 for its ability to simulate prolonged anabolic signaling in controlled environments, which helps in studying cellular adaptation and metabolic responses.
IGF-1 LR3 1mg should always be handled in controlled laboratory environments following appropriate safety and sterility protocols. Researchers use precise measurement tools and sterile equipment to ensure accuracy and prevent contamination.
Because it is classified as a research peptide, its use is subject to regulatory guidelines that vary depending on jurisdiction. Compliance with institutional and legal requirements is essential when handling IGF-1 LR3 in any scientific setting.
Proper documentation, storage, and handling procedures ensure data integrity and experimental reliability.
Mon – Fri : 8:30 – 18:00
chroma peptides © 2026 Created
Reviews
There are no reviews yet.